Breast Surgery

Breast Surgery

The Department of Breast Surgery of the Obstetrics and Gynecology Hospital Affiliated with Fudan University is authorized to confer doctoral degrees. The department carries forward the century-old heritage and brand spirit of Red House Hospital, takes discipline development as its foundation and clinical diagnosis and treatment as its application, places emphasis on the training of professional personnel, and is committed to the multidisciplinary, individualized, and whole-course management of women’s breast health. Professor Wu Kejin, the current Director of the Department of Breast Surgery, leads the team in working with unified purpose and concerted effort, promoting all-round development in medical care, education, and research and achieving remarkable results. The annual number of outpatient visits exceeds 100,000, and the annual number of day-case and inpatient surgeries exceeds 5,000. The number of breast cancer surgeries ranks among the highest in Shanghai’s Grade IIIA hospitals. The department undertakes multidimensional professional medical education and teaching responsibilities. The Red House Alliance for the Prevention and Treatment of Breast Diseases, established by the department, disseminates advanced diagnostic and treatment technologies and concepts nationwide through multidisciplinary discussions within the medical alliance, remote consultations, and other means. As a “Breast Cancer Screening and Prevention and Treatment Training Base of the China Maternal and Child Health Association,” the department trains primary-level physicians, disseminates knowledge of breast health, and promotes the screening and follow-up of breast diseases to achieve early detection and early diagnosis of breast cancer. As a “Standardized Diagnosis and Treatment of Breast Diseases and Minimally Invasive Vacuum-Assisted Breast Biopsy Training Base of the Chinese Medical Doctor Association,” the department regularly conducts professional training courses, demonstrates surgical techniques, and promotes standardized diagnosis and treatment of breast diseases. The department organizes the Red House Breast Disease Summit Forum, the Individualized Precision Treatment Training Course for Breast Tumors in Women of Reproductive Age, and other events, inviting academic pioneers and leading experts from China and abroad to discuss academic frontiers and research hotspots and to share the latest professional advances. The department focuses on basic and translational clinical research on breast diseases and is one of the national multicenter clinical drug trial bases. It participates in relevant integrated cutting-edge research conducted by the hospital’s “Key Laboratory of Female Reproductive Endocrinology” and in collaborative research conducted domestically and internationally, as well as between universities and between hospitals. The department has led numerous research projects funded by the National Natural Science Foundation of China, the National Health Commission, the Shanghai Municipal Commission of Science and Technology, and the Education Commission, among others, and has published more than 100 papers, including more than 30 indexed by SCI, with an impact factor exceeding 8 for an individual paper, and holds 3 invention patents.

Department Highlights

The Department of Breast Surgery has refined its disciplinary development and established three prominent areas: early diagnosis and precision treatment of breast cancer, minimally invasive breast plastic and reconstructive surgery, and the diagnosis and treatment of benign breast diseases. On this basis, it has established relevant specialty clinics. Using young-onset breast cancer as a key focus, the department has taken the lead in implementing systematic treatment models including breast plastic surgery and ovarian function protection and fertility preservation, thereby further improving patients’ quality of life while achieving radical treatment of tumors. Early diagnosis and precision treatment of breast cancer include the use of advanced imaging diagnostic technologies such as TOMO and MRI to detect breast lesions at an early stage and provide precise surgical treatment and precise systemic treatment. Upholding the concept that “less is more,” the department performs a series of procedures, including breast-conserving surgery for breast cancer, sentinel lymph node biopsy, autologous fat transplantation, and immediate reconstruction after tumor surgery, reducing trauma while curing disease. In accordance with domestic and international diagnosis and treatment guidelines and expert consensus, multidisciplinary medical experts conduct regular discussions to implement standardized, comprehensive, and individualized treatment. The department has accumulated substantial experience in the diagnosis and treatment of pregnancy-associated breast cancer and hereditary breast and ovarian cancer, providing patients with professional guidance and subsequent medical services related to oncofertility and genetic counseling. Minimally invasive breast cosmetic surgery is a major highlight of the department. Integrating plastic and reconstructive techniques with surgical techniques, it keeps pace with medical advances, social development, and individual needs to serve patients. The diagnosis and treatment of benign breast diseases focus on the management of common conditions such as lactational mastitis, nipple discharge, and mammary hyperplasia. The department has accumulated considerable experience in these areas, ensuring that cases are neither missed nor misdiagnosed.

Teaching

The Department of Breast Surgery is authorized to confer doctoral degrees in surgery and undertakes postgraduate clinical teaching for Shanghai Medical College of Fudan University. Each year, it conducts national continuing education courses to advance breast disease diagnosis and treatment skills and concepts among fellow physicians. The department accepts visiting physicians for further training, provides a demonstrative role in actual clinical work, and enhances their professional skills and professional competence.

Research

Physicians at all levels have a strong interest in basic and clinical research. In recent years, they have successively led numerous research projects funded by the National Natural Science Foundation of China, the National Health Commission, the Shanghai Municipal Commission of Science and Technology, the Education Commission, and the Health Commission, among others; registered 2 clinical trials; published more than 100 papers, including more than 30 indexed by SCI, with an impact factor exceeding 8 for an individual paper; and obtained 3 invention patents.

Department Experts